⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Laboratoires SMB SA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Laboratoires SMB SA
↗Brussels, Belgium
Laboratoires SMB is a Belgian, family-owned pharmaceutical company founded in 1953. The company specializes in the development and manufacture of high-quality medicines, with a strong focus on innovative drug delivery systems, including oral and pulmonary delivery technologies such as micropellets, semi-solid lipidic matrices (Lidose®), and dry powder inhalers.
Operating globally with products distributed in over 50 countries, SMB integrates R&D, clinical trials, regulatory affairs, and production. The company maintains a commitment to scientific excellence and patient-centered care, leveraging its heritage to address unmet medical needs through advanced galenic formulations.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$50M-$100M
Founded:1953
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Oral drug delivery, Pulmonary drug delivery
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:S.M.B. Technology S.A.
Key Partnerships:GALEPHAR M/F (Contract R&D)
COMPETITION
Position:Niche Player
Competitors:UCB, Janssen Pharmaceutica
LEADERSHIP
Key Executives:
Philippe Baudier - Managing Director
LINKS
Website:smb.be
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Laboratoires SMB SA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.